laiv

Initial concerns over the safety of LAIV among children with asthma stemmed from the results of a larger randomized, double-blind, placebo-controlled safety trial in healthy children conducted by Bergen et al. laiv drw sdy 6 Children were randomly selected 2:1 to receive either LAIV or placebo; enrolled children were followed for 42 days after each